Research at Ghent University, in collaboration with The University of British Columbia, has shown that continuous freeze-drying of mRNA LNPs enables long-term storage at higher temperatures for months without losing their transfection properties.

The full article can be read and downloaded here

Please contact us via info@rheavita.com if you wish to learn more about how continuous freeze-drying enables the stabilization of your mRNA therapy for distribution and storage.

For formulation development, the freeze-drying process development, and production, we can be your partner in getting your therapy fast to the market with the highest quality while avoiding cold chain logistics.